Top Markets
Coin of the day
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Peringkat dalam Saham #28218
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Harga Saham
$0.4
Terakhir disinkronkan: 2026-10-02
Kapitalisasi Pasar
$27.18M
Perubahan (1 hari)
-14.88%
Perubahan (1 tahun)
8.11%
Negara
US
Perdagangan Cell Source, Inc. (CLCS)

Kategori

Riwayat pemecahan saham untuk Cell Source, Inc. (CLCS)
Saham Cell Source, Inc. (simbol: CLCS) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 06, 2026.
Satu lembar saham CLCS yang dibeli sebelum Oct 06, 2026 sekarang setara dengan 0 lembar saham CLCS.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH